Audio: Clinical Impact of New Data From ACG and DDW

Put the latest IBD data presented at the ACG and DDW meetings into practice by listening to this brief audio from our live program.
Francis Farraye Headshot
Francis A. Farraye, MD, MSc
Format: .mp3
File Size: 5.18 MB
Released: November 7, 2018


Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)

Supported by educational grants from
Celgene Corporation

Related Content

David Schwartz, MD, and Baldeep Pabla, MD: expert viewpoint on data from 2019 Crohn’s & Colitis Congress for mirikizumab, SHP647, ustekinumab in IBD

Baldeep S. Pabla, MD, MSCI David A. Schwartz, MD, FACG, AGAF Released: June 26, 2019

D. Brent Polk, MD, expert viewpoint on data from Crohn’s & Colitis Congress 2019 on proactive vs reactive drug monitoring approaches in IBD

D. Brent Polk, MD, AGAF Released: June 7, 2019

Full IBD slides: New Crohn’s and ulcerative colitis clinical data from ACG and DDW 2018. From Francis A. Farraye, MD, MSc.

Francis Farraye Headshot Francis A. Farraye, MD, MSc Released: October 25, 2018

Emerging Crohn’s and ulcerative colitis treatments and targets: integrins, JAK inhibitors, IL-12/23 inhibitors, S1P1 modulators, fecal transplant (FMT)

Gary Lichtenstein Headshot Gary R. Lichtenstein, MD Released: October 3, 2018

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?